Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism CK1δ inhibitors(casein kinase 1 delta inhibitors), CK1ε inhibitors(casein kinase 1 epsilon inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H17FN6 |
InChIKeyKINPMBFCIYMYBU-UHFFFAOYSA-N |
CAS Registry2377691-79-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hematologic Neoplasms | Preclinical | Czechia | 02 Feb 2023 |





